214 related articles for article (PubMed ID: 9013392)
1. Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain: a post mortem in situ hybridization study with special reference to Parkinson's disease.
Hunot S; Bernard V; Faucheux B; Boissière F; Leguern E; Brana C; Gautris PP; Guérin J; Bloch B; Agid Y; Hirsch EC
J Neural Transm (Vienna); 1996; 103(8-9):1043-52. PubMed ID: 9013392
[TBL] [Abstract][Full Text] [Related]
2. Gene expression patterns for GDNF and its receptors in the human putamen affected by Parkinson's disease: a real-time PCR study.
Bäckman CM; Shan L; Zhang YJ; Hoffer BJ; Leonard S; Troncoso JC; Vonsatel P; Tomac AC
Mol Cell Endocrinol; 2006 Jun; 252(1-2):160-6. PubMed ID: 16644101
[TBL] [Abstract][Full Text] [Related]
3. Expression of GDNF mRNA in rat and human nervous tissue.
Springer JE; Mu X; Bergmann LW; Trojanowski JQ
Exp Neurol; 1994 Jun; 127(2):167-70. PubMed ID: 8033959
[TBL] [Abstract][Full Text] [Related]
4. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
7. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
[TBL] [Abstract][Full Text] [Related]
8. Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization.
Pochon NA; Menoud A; Tseng JL; Zurn AD; Aebischer P
Eur J Neurosci; 1997 Mar; 9(3):463-71. PubMed ID: 9104588
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the glial cell line-derived neurotrophic factor gene in Parkinson's disease.
Wartiovaara K; Hytönen M; Vuori M; Paulin L; Rinne J; Sariola H
Exp Neurol; 1998 Aug; 152(2):307-9. PubMed ID: 9710530
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
Strömberg I; Björklund L; Johansson M; Tomac A; Collins F; Olson L; Hoffer B; Humpel C
Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
[TBL] [Abstract][Full Text] [Related]
11. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease.
Törnqvist N; Björklund L; Almqvist P; Wahlberg L; Strömberg I
Exp Neurol; 2000 Jul; 164(1):130-8. PubMed ID: 10877923
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor: a novel therapeutic approach to treat motor dysfunction in Parkinson's disease.
Lapchak PA; Gash DM; Jiao S; Miller PJ; Hilt D
Exp Neurol; 1997 Mar; 144(1):29-34. PubMed ID: 9126148
[TBL] [Abstract][Full Text] [Related]
13. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
14. Depletion of glial cell line-derived neurotrophic factor in substantia nigra neurons of Parkinson's disease brain.
Chauhan NB; Siegel GJ; Lee JM
J Chem Neuroanat; 2001 Jun; 21(4):277-88. PubMed ID: 11429269
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI
Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990
[TBL] [Abstract][Full Text] [Related]
16. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
17. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.
Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC
Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166
[TBL] [Abstract][Full Text] [Related]
18. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
Hoban DB; Howard L; Dowd E
Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
[TBL] [Abstract][Full Text] [Related]
19. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
20. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
Meyer M; Johansen J; Gramsbergen JB; Johansen TE; Zimmer J
Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]